215 related articles for article (PubMed ID: 28425971)
1. ρ⁰ Cells Feature De-Ubiquitination of SLC Transporters and Increased Levels and Fluxes of Amino Acids.
Medina AB; Banaszczak M; Ni Y; Aretz I; Meierhofer D
Int J Mol Sci; 2017 Apr; 18(4):. PubMed ID: 28425971
[TBL] [Abstract][Full Text] [Related]
2. An Impaired Respiratory Electron Chain Triggers Down-regulation of the Energy Metabolism and De-ubiquitination of Solute Carrier Amino Acid Transporters.
Aretz I; Hardt C; Wittig I; Meierhofer D
Mol Cell Proteomics; 2016 May; 15(5):1526-38. PubMed ID: 26852163
[TBL] [Abstract][Full Text] [Related]
3. Post-translational modifications of transporters.
Czuba LC; Hillgren KM; Swaan PW
Pharmacol Ther; 2018 Dec; 192():88-99. PubMed ID: 29966598
[TBL] [Abstract][Full Text] [Related]
4. Expression analysis of human solute carrier (SLC) family transporters in nasal mucosa and RPMI 2650 cells.
Dolberg AM; Reichl S
Eur J Pharm Sci; 2018 Oct; 123():277-294. PubMed ID: 30041030
[TBL] [Abstract][Full Text] [Related]
5. The SLC transporter in nutrient and metabolic sensing, regulation, and drug development.
Zhang Y; Zhang Y; Sun K; Meng Z; Chen L
J Mol Cell Biol; 2019 Jan; 11(1):1-13. PubMed ID: 30239845
[TBL] [Abstract][Full Text] [Related]
6. Amino acid transporters within the solute carrier superfamily: Underappreciated proteins and novel opportunities for cancer therapy.
Hushmandi K; Einollahi B; Saadat SH; Lee EHC; Farani MR; Okina E; Huh YS; Nabavi N; Salimimoghadam S; Kumar AP
Mol Metab; 2024 Jun; 84():101952. PubMed ID: 38705513
[TBL] [Abstract][Full Text] [Related]
7. Potentiating SLC transporter activity: Emerging drug discovery opportunities.
Rives ML; Javitch JA; Wickenden AD
Biochem Pharmacol; 2017 Jul; 135():1-11. PubMed ID: 28214518
[TBL] [Abstract][Full Text] [Related]
8. Establishment of a novel microscale thermophoresis ligand-binding assay for characterization of SLC solute carriers using oligopeptide transporter PepT1 (SLC15 family) as a model system.
Clémençon B; Lüscher BP; Hediger MA
J Pharmacol Toxicol Methods; 2018; 92():67-76. PubMed ID: 29580877
[TBL] [Abstract][Full Text] [Related]
9. Solute Carrier Transporters as Potential Targets for the Treatment of Metabolic Disease.
Schumann T; König J; Henke C; Willmes DM; Bornstein SR; Jordan J; Fromm MF; Birkenfeld AL
Pharmacol Rev; 2020 Jan; 72(1):343-379. PubMed ID: 31882442
[TBL] [Abstract][Full Text] [Related]
10. Exploiting Cysteine Residues of SLC Membrane Transporters as Targets for Drugs.
Scalise M; Console L; Galluccio M; Pochini L; Tonazzi A; Giangregorio N; Indiveri C
SLAS Discov; 2019 Oct; 24(9):867-881. PubMed ID: 31251685
[TBL] [Abstract][Full Text] [Related]
11. Harnessing Solute Carrier Transporters for Precision Oncology.
Nyquist MD; Prasad B; Mostaghel EA
Molecules; 2017 Mar; 22(4):. PubMed ID: 28350329
[TBL] [Abstract][Full Text] [Related]
12. A widespread role for SLC transmembrane transporters in resistance to cytotoxic drugs.
Girardi E; César-Razquin A; Lindinger S; Papakostas K; Konecka J; Hemmerich J; Kickinger S; Kartnig F; Gürtl B; Klavins K; Sedlyarov V; Ingles-Prieto A; Fiume G; Koren A; Lardeau CH; Kumaran Kandasamy R; Kubicek S; Ecker GF; Superti-Furga G
Nat Chem Biol; 2020 Apr; 16(4):469-478. PubMed ID: 32152546
[TBL] [Abstract][Full Text] [Related]
13. Transporter-Mediated Drug Delivery.
Gyimesi G; Hediger MA
Molecules; 2023 Jan; 28(3):. PubMed ID: 36770817
[TBL] [Abstract][Full Text] [Related]
14. Amino Acids and Their Transporters in T Cell Immunity and Cancer Therapy.
Wang W; Zou W
Mol Cell; 2020 Nov; 80(3):384-395. PubMed ID: 32997964
[TBL] [Abstract][Full Text] [Related]
15. Kinetic Models of Secondary Active Transporters.
Burtscher V; Schicker K; Freissmuth M; Sandtner W
Int J Mol Sci; 2019 Oct; 20(21):. PubMed ID: 31661895
[TBL] [Abstract][Full Text] [Related]
16. A guide to plasma membrane solute carrier proteins.
Pizzagalli MD; Bensimon A; Superti-Furga G
FEBS J; 2021 May; 288(9):2784-2835. PubMed ID: 32810346
[TBL] [Abstract][Full Text] [Related]
17. Solute Carriers in the Blood-Brain Barier: Safety in Abundance.
Nałęcz KA
Neurochem Res; 2017 Mar; 42(3):795-809. PubMed ID: 27503090
[TBL] [Abstract][Full Text] [Related]
18. Unraveling 'The Cancer Genome Atlas' information on the role of SLC transporters in anticancer drug uptake.
Al-Abdulla R; Perez-Silva L; Abete L; Romero MR; Briz O; Marin JJG
Expert Rev Clin Pharmacol; 2019 Apr; 12(4):329-341. PubMed ID: 30744443
[TBL] [Abstract][Full Text] [Related]
19. Classification Systems of Secondary Active Transporters.
Perland E; Fredriksson R
Trends Pharmacol Sci; 2017 Mar; 38(3):305-315. PubMed ID: 27939446
[TBL] [Abstract][Full Text] [Related]
20. Cell-surface SLC nucleoside transporters and purine levels modulate BRD4-dependent chromatin states.
Li KC; Girardi E; Kartnig F; Grosche S; Pemovska T; Bigenzahn JW; Goldmann U; Sedlyarov V; Bensimon A; Schick S; Lin JG; Gürtl B; Reil D; Klavins K; Kubicek S; Sdelci S; Superti-Furga G
Nat Metab; 2021 May; 3(5):651-664. PubMed ID: 33972798
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
